stockportfolio.pro
CI vs COR: Which Stock Is the Better Buy?
The Cigna Group and Cencora, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — CI vs COR, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| The Cigna Group (CI) | Cencora, Inc. (COR) | |
|---|---|---|
| Market cap | $76.1B | $57.7B |
| Revenue (latest FY) | $274.90B | $321.33B |
| Net income (latest FY) | $5.96B | $1.55B |
| Revenue growth (5y CAGR) | 11.4% | 11.1% |
| Net margin | 2.2% | 0.5% |
| Return on equity | 14.3% | 103.1% |
| P/E ratio | 12.2 | 22.7 |
| Dividend yield | 2.2% | 0.8% |
| Profitable years (of last 10) | 10 | 9 |
| Positive free cash flow | — | Yes |
See the full CI vs COR breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open CI's full financials → Open COR's full financials →Frequently asked questions
Which is bigger, CI or COR?
The Cigna Group is larger by market capitalization — $76.1B versus $57.7B.
Which grows faster, CI or COR?
Over the last five fiscal years, The Cigna Group grew revenue faster — 11.4%/yr versus 11.1%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.